Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

cbdMD (YCBD) Current Deferred Revenue (2017 - 2025)

cbdMD (YCBD) has disclosed Current Deferred Revenue for 8 consecutive years, with $488626.0 as the latest value for Q4 2025.

  • Quarterly Current Deferred Revenue fell 7.36% to $488626.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $488626.0 through Dec 2025, down 7.36% year-over-year, with the annual reading at $506289.0 for FY2025, 0.6% up from the prior year.
  • Current Deferred Revenue hit $488626.0 in Q4 2025 for cbdMD, down from $506289.0 in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $557353.0 in Q1 2025 to a low of $755.0 in Q2 2021.
  • Historically, Current Deferred Revenue has averaged $429667.4 across 4 years, with a median of $504771.5 in 2024.
  • Biggest five-year swings in Current Deferred Revenue: skyrocketed 171.67% in 2024 and later fell 7.43% in 2025.
  • Year by year, Current Deferred Revenue stood at $755.0 in 2021, then skyrocketed by 24435.89% to $185246.0 in 2023, then skyrocketed by 184.72% to $527438.0 in 2024, then dropped by 7.36% to $488626.0 in 2025.
  • Business Quant data shows Current Deferred Revenue for YCBD at $488626.0 in Q4 2025, $506289.0 in Q3 2025, and $509198.0 in Q2 2025.